Research ArticleArticle
Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study
Clementina López-Medina, Anna Moltó and Maxime Dougados
The Journal of Rheumatology April 2019, jrheum.181331; DOI: https://doi.org/10.3899/jrheum.181331
Clementina López-Medina
From the Rheumatology Department, Cochin Hospital, Paris; INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris- Cité, Paris, France; Department of Medicine, University of Córdoba, Córdoba, Spain. The ASAS-COMOSPA study was conducted under the umbrella of ASAS and was financially supported by unrestricted grants from AbbVie, Pfizer, and UCB. C. López-Medina, MD, PhD, Rheumatology Department, Cochin Hospital, INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, and Department of Medicine, University of Córdoba; A. Moltó, MD, PhD, Rheumatology Department, Cochin Hospital, and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité; M. Dougados, MD, PhD, Rheumatology Department, Cochin Hospital, and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité. Address correspondence to Dr. C. López-Medina, Rheumatology Department, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. E-mail: clementinalopezmedina@gmail.com. Accepted for publication March 26, 2019.
Anna Moltó
From the Rheumatology Department, Cochin Hospital, Paris; INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris- Cité, Paris, France; Department of Medicine, University of Córdoba, Córdoba, Spain. The ASAS-COMOSPA study was conducted under the umbrella of ASAS and was financially supported by unrestricted grants from AbbVie, Pfizer, and UCB. C. López-Medina, MD, PhD, Rheumatology Department, Cochin Hospital, INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, and Department of Medicine, University of Córdoba; A. Moltó, MD, PhD, Rheumatology Department, Cochin Hospital, and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité; M. Dougados, MD, PhD, Rheumatology Department, Cochin Hospital, and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité. Address correspondence to Dr. C. López-Medina, Rheumatology Department, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. E-mail: clementinalopezmedina@gmail.com. Accepted for publication March 26, 2019.
Maxime Dougados
From the Rheumatology Department, Cochin Hospital, Paris; INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris- Cité, Paris, France; Department of Medicine, University of Córdoba, Córdoba, Spain. The ASAS-COMOSPA study was conducted under the umbrella of ASAS and was financially supported by unrestricted grants from AbbVie, Pfizer, and UCB. C. López-Medina, MD, PhD, Rheumatology Department, Cochin Hospital, INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, and Department of Medicine, University of Córdoba; A. Moltó, MD, PhD, Rheumatology Department, Cochin Hospital, and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité; M. Dougados, MD, PhD, Rheumatology Department, Cochin Hospital, and INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité. Address correspondence to Dr. C. López-Medina, Rheumatology Department, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. E-mail: clementinalopezmedina@gmail.com. Accepted for publication March 26, 2019.
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA Study
Clementina López-Medina, Anna Moltó, Maxime Dougados
The Journal of Rheumatology Apr 2019, jrheum.181331; DOI: 10.3899/jrheum.181331